In the trial note that even though 20 patients were added the unblinding occured with "approximately one-half the number of patients ORIGINALLY targeted for enrollment."
If they unblinded the data wouldn't they have had an early read at that point weather it was even worth it to continue the study and bother with enrolling more patients?
Market Data 
Markets 
AI
